Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity

v3.22.1
Condensed Statements of Stockholders' Equity - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ 9,784,356 $ 10,051 $ 24,805,929 $ (15,031,624)
Beginning balance, Shares at Dec. 31, 2020   10,050,849    
Stock-based compensation expense 591,124   591,124  
Warrant expense 237,768   237,768  
Issuance of common stock 60,391 $ 9 60,382  
Issuance of common stock, Shares   9,000    
Net loss (2,637,068)     (2,637,068)
Ending balance at Mar. 31, 2021 8,036,571 $ 10,060 25,695,203 (17,668,692)
Ending balance, Shares at Mar. 31, 2021   10,059,849    
Beginning balance at Dec. 31, 2021 $ 38,415,549 $ 25,155 68,208,081 (29,817,687)
Beginning balance, Shares at Dec. 31, 2021 25,155,198 25,155,198    
Stock-based compensation expense $ 123,229   123,229  
Warrant expense 0      
Issuance of common stock 67,000 $ 50 66,950  
Issuance of common stock, Shares   50,000    
Issuance of common stock, stock options exercised 44,142 $ 22 44,120  
Issuance of common stock, stock options exercised, Shares   21,853    
Net loss (4,640,601)     (4,640,601)
Ending balance at Mar. 31, 2022 $ 34,009,319 $ 25,227 $ 68,442,380 $ (34,458,288)
Ending balance, Shares at Mar. 31, 2022 25,227,051 25,227,051